US Patent Issued to The Board of Trustees of the Leland Stanford Junior University on July 14 for "Immunostimulatory toll-like receptor agonist-nanoparticle for cancer immunotherapy" (California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,516, issued on July 14, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.).

"Immunostimulatory toll-like receptor agonist-nanoparticle for cancer immunotherapy" was invented by Qian Yin (Los Altos, Calif.) and Mark M. Davis (Atherton, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods are provided relating to immunostimulatory TLR agonist nanoparticle formulations. Methods are provided for treating cancer, by stimulating an immune response to cancer cells through administering to an individual mammal an effective dose or series of doses of an immunostimulatory composition com...